Alfred Altomari Agile Therapeutics Inc (AGRX) insider trading activity

Alfred Altomari is Chief Executive Officer of AGILE THERAPEUTICS INC. Currently has a direct ownership of 0 shares of AGRX, which is worth approximately $0. The most recent transaction as insider was on Aug 26, 2024, when has been sold 47,749 shares (Common Stock) at a price of $1.52 per share, resulting in proceeds of $72,578. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

ALFRED ALTOMARI Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 26 2024	SELL Sale (or disposition) back to the issuer	$72,578 $1.52 p/Share	47,749 Reduced 100.0%	0 Common Stock
Jun 28 2023	BUY Grant, award, or other acquisition	-	46,463 Added 49.32%	47,749 Common Stock
Aug 26 2022	BUY Open market or private purchase	$22,500 $0.45 p/Share	50,000 Added 43.73%	64,343 Common Stock
Oct 13 2021	BUY Open market or private purchase	-	58,824 Added 9.3%	573,734 Common Stock
Jul 29 2021	BUY Open market or private purchase	$33,012 $1.26 p/Share	26,200 Added 4.84%	514,910 Common Stock
May 18 2021	BUY Open market or private purchase	$32,200 $1.61 p/Share	20,000 Added 3.93%	488,710 Common Stock
Mar 23 2021	BUY Open market or private purchase	$25,000 $2.0 p/Share	12,500 Added 2.6%	468,710 Common Stock

Also insider at

BXRX

Baudax Bio, Inc. Healthcare

Director

INSM

INSMED Inc Healthcare

Director

Alfred Altomari

Chief Executive Officer

Princeton, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGRX shares.

Notify only if

Value

Insider Trading

Get notified when an Agile Therapeutics Inc insider buys or sells AGRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to AGILE THERAPEUTICS INC

Track Activities on AGRX

Account